Literature DB >> 22212900

Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

Laura M Ensign1, Richard Cone, Justin Hanes.   

Abstract

Oral delivery is the most common method for drug administration. However, poor solubility, stability, and bioavailability of many drugs make achieving therapeutic levels via the gastrointestinal (GI) tract challenging. Drug delivery must overcome numerous hurdles, including the acidic gastric environment and the continuous secretion of mucus that protects the GI tract. Nanoparticle drug carriers that can shield drugs from degradation and deliver them to intended sites within the GI tract may enable more efficient and sustained drug delivery. However, the rapid secretion and shedding of GI tract mucus can significantly limit the effectiveness of nanoparticle drug delivery systems. Many types of nanoparticles are efficiently trapped in and rapidly removed by mucus, making controlled release in the GI tract difficult. This review addresses the protective barrier properties of mucus secretions, how mucus affects the fate of orally administered nanoparticles, and recent developments in nanoparticles engineered to penetrate the mucus barrier.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22212900      PMCID: PMC3322271          DOI: 10.1016/j.addr.2011.12.009

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  114 in total

1.  Migration of adhesive and nonadhesive particles in the rat intestine under altered mucus secretion conditions.

Authors:  B Tirosh; A Rubinstein
Journal:  J Pharm Sci       Date:  1998-04       Impact factor: 3.534

2.  The influence of intestinal mucus components on the diffusion of drugs.

Authors:  A W Larhed; P Artursson; E Björk
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

3.  Measurement of gastrointestinal pH profiles in normal ambulant human subjects.

Authors:  D F Evans; G Pye; R Bramley; A G Clark; T J Dyson; J D Hardcastle
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

4.  A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents.

Authors:  S Kerss; A Allen; A Garner
Journal:  Clin Sci (Lond)       Date:  1982-08       Impact factor: 6.124

Review 5.  pH-Responsive nanoparticles for drug delivery.

Authors:  Weiwei Gao; Juliana M Chan; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

6.  Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis.

Authors:  Rob J Longman; Richard Poulsom; Anthony P Corfield; Bryan F Warren; Nicholas A Wright; Michael G Thomas
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

7.  Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.

Authors:  Jung Soo Suk; Samuel K Lai; Nicholas J Boylan; Michelle R Dawson; Michael P Boyle; Justin Hanes
Journal:  Nanomedicine (Lond)       Date:  2011-02       Impact factor: 5.307

8.  Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).

Authors:  Mayank D Bhavsar; Mansoor M Amiji
Journal:  J Control Release       Date:  2007-03-15       Impact factor: 9.776

9.  In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors.

Authors:  Anekant Jain; Sanjay K Jain
Journal:  Eur J Pharm Sci       Date:  2008-09-07       Impact factor: 4.384

10.  Altering mucus rheology to "solidify" human mucus at the nanoscale.

Authors:  Samuel K Lai; Ying-Ying Wang; Richard Cone; Denis Wirtz; Justin Hanes
Journal:  PLoS One       Date:  2009-01-28       Impact factor: 3.240

View more
  204 in total

Review 1.  Oral delivery of biologics using drug-device combinations.

Authors:  Ester Caffarel-Salvador; Alex Abramson; Robert Langer; Giovanni Traverso
Journal:  Curr Opin Pharmacol       Date:  2017-08-02       Impact factor: 5.547

Review 2.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

3.  Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.

Authors:  Susanne Beyer; Aline Moosmann; Astrid S Kahnt; Thomas Ulshöfer; Michael J Parnham; Nerea Ferreirós; Sylvia Wagner; Matthias G Wacker
Journal:  Pharm Res       Date:  2015-07-28       Impact factor: 4.200

4.  Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.

Authors:  Mahta Samizadeh; Xiaoping Zhang; Simi Gunaseelan; Antoinette G Nelson; Matthew S Palombo; Daniel R Myers; Yashveer Singh; Usha Ganapathi; Zoltan Szekely; Patrick J Sinko
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

5.  Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.

Authors:  Carl M Schoellhammer; Gregory Y Lauwers; Jeremy A Goettel; Matthias A Oberli; Cody Cleveland; June Y Park; Daniel Minahan; Yiyun Chen; Daniel G Anderson; Ana Jaklenec; Scott B Snapper; Robert Langer; Giovanni Traverso
Journal:  Gastroenterology       Date:  2017-01-11       Impact factor: 22.682

6.  Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.

Authors:  Jiang-Jiang Qin; Wei Wang; Sushanta Sarkar; Ruiwen Zhang
Journal:  J Control Release       Date:  2016-07-06       Impact factor: 9.776

7.  Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

Authors:  Sara M Navarro; Caleb Darensbourg; Linda Cross; Rhett Stout; Diana Coulon; Carlos E Astete; Timothy Morgan; Cristina M Sabliov
Journal:  Ther Deliv       Date:  2014-11

Review 8.  Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.

Authors:  Hedieh Malekzad; Hamed Mirshekari; Parham Sahandi Zangabad; S M Moosavi Basri; Fazel Baniasadi; Maryam Sharifi Aghdam; Mahdi Karimi; Michael R Hamblin
Journal:  Crit Rev Biotechnol       Date:  2017-04-24       Impact factor: 8.429

Review 9.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

Review 10.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.